SOP 16. REPORTING REQUIREMENTS FOR UNANTICIPATED PROBLEMS,

First Page		Document Content
Date: 2014-03-10 08:07:42 Clinical research Pharmacology Drug safety Pharmaceutical industry Adverse event Institutional review board Food and Drug Administration National Institutes of Health Adverse effect Medicine Health Research		SOP 16. REPORTING REQUIREMENTS FOR UNANTICIPATED PROBLEMS, Add to Reading List Source URL: ohsr.od.nih.gov Download Document from Source Website File Size: 1,09 MB Share Document on Facebook

	PDF Document DocID: 1xvUb - View Document
	PDF Document DocID: 1xc8R - View Document
	Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME DocID: 1vqsj - View Document
	Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia DocID: 1vlJU - View Document
	Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology DocID: 1vk1K - View Document